GLP1R and neoplasm: In preclinical models of pancreatic cancer, Zhao et al. found that GLP-1R activation reduced tumor growth and metastatic potential by inhibiting ERK1/2 and AKT phosphorylation, lowering MMP-2 and MMP-9 expression, and increasing E-cadherin.